Global Prostate Cancer Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends
The report focuses on the Prostate Cancer Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Prostate Cancer Drugs market.
Major Players in the Prostate Cancer Drugs market are:
Medivation
Bayer
Sanofi
Nippon Shinyaku
Merck & Co., Inc.
Novartis
Astellas
Johnson & Johnson
On the basis of types, the Prostate Cancer Drugs market is primarily split into:
Abiraterone Acetate
Apalutamide
Bicalutamide
Cabazitaxel
Casodex (Bicalutamide)
Darolutamide
Degarelix
Docetaxel
On the basis of applications, the market covers:
Hospitals Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
- 1 Prostate Cancer Drugs Market Overview
- 1.1 Product Overview and Scope of Prostate Cancer Drugs Market
- 1.2 Prostate Cancer Drugs Market Segment by Type
- 1.2.1 Global Prostate Cancer Drugs Market Sales and CAGR (%) Comparison by Type (2017-2029)
- 1.3 Global Prostate Cancer Drugs Market Segment by Application
- 1.3.1 Prostate Cancer Drugs Market Consumption (Sales) Comparison by Application (2017-2029)
- 1.4 Global Prostate Cancer Drugs Market, Region Wise (2017-2029)
- 1.5 Global Market Size (Revenue) of Prostate Cancer Drugs (2017-2029)
- 1.5.1 Global Prostate Cancer Drugs Market Revenue Status and Outlook (2017-2029)
- 1.5.2 Global Prostate Cancer Drugs Market Sales Status and Outlook (2017-2029)
- 1.6 Influence of Regional Conflicts on the Prostate Cancer Drugs Industry
- 1.7 Impact of Carbon Neutrality on the Prostate Cancer Drugs Industry
- 2 Prostate Cancer Drugs Market Upstream and Downstream Analysis
- 2.1 Prostate Cancer Drugs Industrial Chain Analysis
- 2.2 Key Raw Materials Suppliers and Price Analysis
- 2.3 Key Raw Materials Supply and Demand Analysis
- 2.4 Market Concentration Rate of Raw Materials
- 2.5 Manufacturing Process Analysis
- 2.6 Manufacturing Cost Structure Analysis
- 2.6.1 Labor Cost Analysis
- 2.6.2 Energy Costs Analysis
- 2.6.3 R&D Costs Analysis
- 2.7 Major Downstream Buyers of Prostate Cancer Drugs Analysis
- 2.8 Impact of COVID-19 on the Industry Upstream and Downstream
- 3 Players Profiles
- 3.1 Medivation
- 3.1.1 Medivation Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.1.2 Product Profiles, Application and Specification
- 3.1.3 Prostate Cancer Drugs Market Performance (2017-2022)
- 3.1.4 Business Overview
- 3.2 Bayer
- 3.2.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.2.2 Product Profiles, Application and Specification
- 3.2.3 Prostate Cancer Drugs Market Performance (2017-2022)
- 3.2.4 Business Overview
- 3.3 Sanofi
- 3.3.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.3.2 Product Profiles, Application and Specification
- 3.3.3 Prostate Cancer Drugs Market Performance (2017-2022)
- 3.3.4 Business Overview
- 3.4 Nippon Shinyaku
- 3.4.1 Nippon Shinyaku Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.4.2 Product Profiles, Application and Specification
- 3.4.3 Prostate Cancer Drugs Market Performance (2017-2022)
- 3.4.4 Business Overview
- 3.5 Merck & Co., Inc.
- 3.5.1 Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.5.2 Product Profiles, Application and Specification
- 3.5.3 Prostate Cancer Drugs Market Performance (2017-2022)
- 3.5.4 Business Overview
- 3.6 Novartis
- 3.6.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.6.2 Product Profiles, Application and Specification
- 3.6.3 Prostate Cancer Drugs Market Performance (2017-2022)
- 3.6.4 Business Overview
- 3.7 Astellas
- 3.7.1 Astellas Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.7.2 Product Profiles, Application and Specification
- 3.7.3 Prostate Cancer Drugs Market Performance (2017-2022)
- 3.7.4 Business Overview
- 3.8 Johnson & Johnson
- 3.8.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.8.2 Product Profiles, Application and Specification
- 3.8.3 Prostate Cancer Drugs Market Performance (2017-2022)
- 3.8.4 Business Overview
- 4 Global Prostate Cancer Drugs Market Landscape by Player
- 4.1 Global Prostate Cancer Drugs Sales and Share by Player (2017-2022)
- 4.2 Global Prostate Cancer Drugs Revenue and Market Share by Player (2017-2022)
- 4.3 Global Prostate Cancer Drugs Average Price by Player (2017-2022)
- 4.4 Global Prostate Cancer Drugs Gross Margin by Player (2017-2022)
- 4.5 Prostate Cancer Drugs Market Competitive Situation and Trends
- 4.5.1 Prostate Cancer Drugs Market Concentration Rate
- 4.5.2 Prostate Cancer Drugs Market Share of Top 3 and Top 6 Players
- 4.5.3 Mergers & Acquisitions, Expansion
- 5 Global Prostate Cancer Drugs Sales, Revenue, Price Trend by Type
- 5.1 Global Prostate Cancer Drugs Sales and Market Share by Type (2017-2022)
- 5.2 Global Prostate Cancer Drugs Revenue and Market Share by Type (2017-2022)
- 5.3 Global Prostate Cancer Drugs Price by Type (2017-2022)
- 5.4 Global Prostate Cancer Drugs Sales, Revenue and Growth Rate by Type (2017-2022)
- 5.4.1 Global Prostate Cancer Drugs Sales, Revenue and Growth Rate of Abiraterone Acetate (2017-2022)
- 5.4.2 Global Prostate Cancer Drugs Sales, Revenue and Growth Rate of Apalutamide (2017-2022)
- 5.4.3 Global Prostate Cancer Drugs Sales, Revenue and Growth Rate of Bicalutamide (2017-2022)
- 5.4.4 Global Prostate Cancer Drugs Sales, Revenue and Growth Rate of Cabazitaxel (2017-2022)
- 5.4.5 Global Prostate Cancer Drugs Sales, Revenue and Growth Rate of Casodex (Bicalutamide) (2017-2022)
- 5.4.6 Global Prostate Cancer Drugs Sales, Revenue and Growth Rate of Darolutamide (2017-2022)
- 5.4.7 Global Prostate Cancer Drugs Sales, Revenue and Growth Rate of Degarelix (2017-2022)
- 5.4.8 Global Prostate Cancer Drugs Sales, Revenue and Growth Rate of Docetaxel (2017-2022)
- 6 Global Prostate Cancer Drugs Market Analysis by Application
- 6.1 Global Prostate Cancer Drugs Consumption and Market Share by Application (2017-2022)
- 6.2 Global Prostate Cancer Drugs Consumption Revenue and Market Share by Application (2017-2022)
- 6.3 Global Prostate Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
- 6.3.1 Global Prostate Cancer Drugs Consumption and Growth Rate of Hospitals Pharmacies (2017-2022)
- 6.3.2 Global Prostate Cancer Drugs Consumption and Growth Rate of Drug Stores & Retail Pharmacies (2017-2022)
- 6.3.3 Global Prostate Cancer Drugs Consumption and Growth Rate of Online Pharmacies (2017-2022)
- 7 Global Prostate Cancer Drugs Sales and Revenue Region Wise (2017-2022)
- 7.1 Global Prostate Cancer Drugs Sales and Market Share, Region Wise (2017-2022)
- 7.2 Global Prostate Cancer Drugs Revenue and Market Share, Region Wise (2017-2022)
- 7.3 Global Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.4 United States Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.5 Europe Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.6 China Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.7 Japan Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.8 India Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.9 Southeast Asia Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.10 Latin America Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.11 Middle East and Africa Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 8 Global Prostate Cancer Drugs Market Forecast (2022-2029)
- 8.1 Global Prostate Cancer Drugs Sales, Revenue Forecast (2022-2029)
- 8.1.1 Global Prostate Cancer Drugs Sales and Growth Rate Forecast (2022-2029)
- 8.1.2 Global Prostate Cancer Drugs Revenue and Growth Rate Forecast (2022-2029)
- 8.1.3 Global Prostate Cancer Drugs Price and Trend Forecast (2022-2029)
- 8.2 Global Prostate Cancer Drugs Sales and Revenue Forecast, Region Wise (2022-2029)
- 8.2.1 United States Prostate Cancer Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.2 Europe Prostate Cancer Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.3 China Prostate Cancer Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.4 Japan Prostate Cancer Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.5 India Prostate Cancer Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.6 Southeast Asia Prostate Cancer Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.7 Latin America Prostate Cancer Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.8 Middle East and Africa Prostate Cancer Drugs Sales and Revenue Forecast (2022-2029)
- 8.3 Global Prostate Cancer Drugs Sales, Revenue and Price Forecast by Type (2022-2029)
- 8.3.1 Global Prostate Cancer Drugs Revenue and Growth Rate of Abiraterone Acetate (2022-2029)
- 8.3.2 Global Prostate Cancer Drugs Revenue and Growth Rate of Apalutamide (2022-2029)
- 8.3.3 Global Prostate Cancer Drugs Revenue and Growth Rate of Bicalutamide (2022-2029)
- 8.3.4 Global Prostate Cancer Drugs Revenue and Growth Rate of Cabazitaxel (2022-2029)
- 8.3.5 Global Prostate Cancer Drugs Revenue and Growth Rate of Casodex (Bicalutamide) (2022-2029)
- 8.3.6 Global Prostate Cancer Drugs Revenue and Growth Rate of Darolutamide (2022-2029)
- 8.3.7 Global Prostate Cancer Drugs Revenue and Growth Rate of Degarelix (2022-2029)
- 8.3.8 Global Prostate Cancer Drugs Revenue and Growth Rate of Docetaxel (2022-2029)
- 8.4 Global Prostate Cancer Drugs Consumption Forecast by Application (2022-2029)
- 8.4.1 Global Prostate Cancer Drugs Consumption Value and Growth Rate of Hospitals Pharmacies (2022-2029)
- 8.4.2 Global Prostate Cancer Drugs Consumption Value and Growth Rate of Drug Stores & Retail Pharmacies (2022-2029)
- 8.4.3 Global Prostate Cancer Drugs Consumption Value and Growth Rate of Online Pharmacies (2022-2029)
- 8.5 Prostate Cancer Drugs Market Forecast Under COVID-19
- 9 Industry Outlook
- 9.1 Prostate Cancer Drugs Market Drivers Analysis
- 9.2 Prostate Cancer Drugs Market Restraints and Challenges
- 9.3 Prostate Cancer Drugs Market Opportunities Analysis
- 9.4 Emerging Market Trends
- 9.5 Prostate Cancer Drugs Industry Technology Status and Trends
- 9.6 News of Product Release
- 9.7 Consumer Preference Analysis
- 9.8 Prostate Cancer Drugs Industry Development Trends under COVID-19 Outbreak
- 9.8.1 Global COVID-19 Status Overview
- 9.8.2 Influence of COVID-19 Outbreak on Prostate Cancer Drugs Industry Development
- 10 Research Findings and Conclusion
- 11 Appendix
- 11.1 Methodology
- 11.2 Research Data Source
- 1.2 Prostate Cancer Drugs Market Segment by Type
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook